Zavesca Oral Capsule 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Zavesca: Oral capsule (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MIGLUSTAT (MIG loo stat) helps to keep normal blood levels of an enzyme needed to breakdown fat in the body. It is used to treat type 1 Gaucher disease.

Similar Generic Drugs : Miglustat: Oral capsule (100mg)
In-Depth Information

Zavesca 100mg Capsule

NDC: 662150201
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Gaucher Disease

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Zavesca 100mg Capsule

Reported Side Effects for Zavesca 100mg Capsule

Vomiting Incidence:
4.0-11.0%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
4.0-11.0%*
Severity: MILD
Onset: DELAYED
Migraine Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
6.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Irregular Periods Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
8.0-22.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
8.0-11.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Nerve Pain Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
11.0-30.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
17.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
17.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
18.0-67.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
21.0-22.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
29.0-50.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
39.0-67.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
85.0-99.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Third Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Zavesca

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5